HHS Pressed To Reverse Whistleblowers' Reassignment

Strong pressure is being brought to bear on Department of Health and Human Services (HHS) officials to reverse a May personnel action at the National Institutes of Health. That move, to reassign fraud investigators Walter Stewart and Ned Feder to new jobs, effectively ended the pair's controversial scientific misconduct research at the institutes. Tactics to influence administrators have included a 33-day protest fast by Stewart and letters supporting the two men and their work from prominent m

Written byFranklin Hoke
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

At least partly in response to the rising political pressure, department officials acknowledge, HHS agreed June 3 to review the internal personnel transfer. But there are suggestions that neither the scope of the ongoing inquiry nor its eventual outcome will resolve the controversy. Also, no date has been set for completion of the review.

"Certainly, their assignment and reassignment are matters we're going to look at," says Harriet Rabb, HHS general counsel, "just to make sure that every `i' was dotted and every `t' was crossed and that whatever the procedures are that people are entitled to, that those procedures were followed.... If we discover that something should be altered, of course, we'll do it."

The two misconduct researchers ran into trouble with their bosses when they used a computer system of their own design that compares texts for similarities to accuse historian Stephen Oates of plagiarism (Franklin Hoke, The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies